Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery

Xueyang Jiang(China Pharmaceutical University), Haopeng Sun(China Pharmaceutical University), Junting Zhou(China Pharmaceutical University), Tingkai Chen(China Pharmaceutical University), Yao Chen(Nanjing University of Chinese Medicine), Feng Feng(China Pharmaceutical University), Hongyu Yang(China Pharmaceutical University), Siyu He(ShenZhen People’s Hospital), Wei Qu(China Pharmaceutical University)
ACS Medicinal Chemistry Letters
February 9, 2018
10.1021/acsmedchemlett.7b00463
Cited by 117

Related Papers

Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
|Journal of Medicinal Chemistry|2021|196